Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pulmonology
Volume 2014, Article ID 368780, 4 pages
http://dx.doi.org/10.1155/2014/368780
Case Report

Improvement with Infliximab of a Disseminated Sarcoidosis in a Patient with Crohn’s Disease

1Hospices Civils de Lyon, 69003 Lyon, France
2Université de Lyon, 69007 Lyon, France
3Université Lyon1, 69007 Lyon, France
4INRA, UMR754, 69007 Lyon, France

Received 24 November 2013; Accepted 31 December 2013; Published 6 February 2014

Academic Editors: E. Fernández Pérez, S. Ohshimo, T. Peros-Golubicic, and C. van Moorsel

Copyright © 2014 Nader Chebib et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Esmadi, D. S. Ahmad, B. Odum et al., “Sarcoidosis: an extremely rare cause of granulomatous enterocolitis,” Journal of Gastrointestinal and Liver Diseases, vol. 21, no. 4, pp. 423–425, 2012. View at Google Scholar
  2. P. Camus and T. V. Colby, “The lung in inflammatory bowel disease,” European Respiratory Journal, vol. 15, no. 1, pp. 5–10, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Pain-Prado, A. Rais, F. Madhi, C. Orzechowski, B. Dubern, and R. Epaud, “Pulmonary and hepatic nodular lesions precede the diagnosis of Crohn's disease in an 8-year-old girl: a case study and review of the literature,” Acta Paediatrica, vol. 101, no. 2, pp. e86–e89, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Kallel, M. Fekih, I. Ben Ghorbel et al., “Un cas exceptionnel de sarcoidose systemique suivie par une maladie de Crohn: une association fortuite ou lien etiopathogenique?” La Presse Médicale, vol. 39, no. 1, pp. 148–150, 2010. View at Publisher · View at Google Scholar
  5. H. Y. Reynolds, “Sarcoidosis: impact of other illnesses on the presentation and management of multi-organ disease,” Lung, vol. 180, no. 5, pp. 281–299, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. J. H. Park and A. I. Levinson, “Granulomatous-lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID),” Clinical Immunology, vol. 134, no. 2, pp. 97–103, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Drent, K. Mansour, and C. Linssen, “Bronchoalveolar lavage in sarcoidosis,” Seminars in Respiratory and Critical Care Medicine, vol. 28, no. 5, pp. 486–495, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. C. H. van Moorsel and D. C. Christiani, “Genetic susceptibility to sarcoidosis, a chronic inflammatory disorder,” American Journal of Respiratory and Critical Care Medicine, vol. 186, no. 9, pp. 816–818, 2012. View at Publisher · View at Google Scholar
  9. J. T. Tigno-Aranjuez and D. W. Abbott, “Ubiquitination and phosphorylation in the regulation of NOD2 signaling and NOD2-mediated disease,” Biochimica et Biophysica Acta, vol. 1823, no. 11, pp. 2022–2028, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Franke, A. Fischer, M. Nothnagel et al., “Genome-wide association analysis in sarcoidosis and Crohn's disease unravels a common susceptibility locus on 10p12.2,” Gastroenterology, vol. 135, no. 4, pp. 1207–1215, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Fischer, B. Schmid, D. Ellinghaus et al., “A novel sarcoidosis risk locus for Europeans on chromosome 11q13.1,” American Journal of Respiratory and Critical Care Medicine, vol. 186, no. 9, pp. 877–885, 2012. View at Publisher · View at Google Scholar
  12. J. F. Mornex, C. Leroux, T. Greenland, and D. Ecochard, “From granuloma to fibrosis in interstitial lung diseases: molecular and cellular interactions,” European Respiratory Journal, vol. 7, no. 4, pp. 779–785, 1994. View at Google Scholar · View at Scopus
  13. C. Abraham and J. H. Cho, “Inflammatory bowel disease,” New England Journal of Medicine, vol. 361, no. 21, pp. 2066–2078, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Peyrin-Biroulet, P. Deltenre, N. de Suray, J. Branche, W. J. Sandborn, and J. Colombel, “Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of Placebo-controlled trials,” Clinical Gastroenterology and Hepatology, vol. 6, no. 6, pp. 644–653, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. R. P. Baughman, E. E. Lower, and M. Drent, “Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them,” Sarcoidosis Vasculitis and Diffuse Lung Diseases, vol. 25, no. 2, pp. 76–89, 2008. View at Google Scholar · View at Scopus
  16. H. Takahashi, K. Kaneta, M. Honma et al., “Sarcoidosis during infliximab therapy for Crohn's disease,” Journal of Dermatology, vol. 37, no. 5, pp. 471–474, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Tong, N. Manolios, G. Howe, and D. Spencer, “New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication,” Internal Medicine Journal, vol. 42, no. 1, pp. 89–94, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Javot, S. Tala, J. Scala-Bertola et al., “Sarcoïdosis and anti-TNF: a paradoxical class effect? Analysis of the French pharmacovigilance system database and literature review,” Therapie, vol. 66, no. 2, pp. 149–154, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. C. A. Parisinos, C. W. Lees, W. A. H. Wallace, and J. Satsangi, “Sarcoidosis complicating treatment with natalizumab for Crohn's disease,” Thorax, vol. 66, no. 12, pp. 1109–1110, 2011. View at Publisher · View at Google Scholar · View at Scopus